Summit Investment Advisors »

Akero Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $156k 6.2k 25.26
2023-12-31 $120k 5.1k 23.35
2023-09-30 $260k 5.1k 50.58
2023-06-30 $173k 3.7k 46.69
2023-03-31 $107k 2.8k 38.26
2022-12-31 $131k 2.8k 47.00
2022-09-30 $68k 2.0k 33.73
2022-06-30 $19k 2.0k 9.42
2022-03-31 $29k 2.0k 14.38
2021-12-31 $43k 2.0k 21.33
2021-09-30 $45k 2.0k 22.32
2021-06-30 $50k 2.0k 24.80
2021-03-31 $28k 970 28.87
2020-12-31 $25k 970 25.77
2020-09-30 $30k 970 30.93
2020-06-30 $18k 730 24.66
2020-03-31 $8.0k 400 20.00
2019-12-31 $9.0k 400 22.50
2019-09-30 $9.0k 400 22.50